The absence of Batf3-dependent cross-presenting cDC1s also abolished a significant proportion of the aCD40 anti-tumor effect, underscoring the essential role of cDC1s in initiating CD8 + T cell-mediated tumor immunity. This evidence concerns the gene CD8A and neoplasm.